Kleanthis Xanthopoulos

Kleanthis Xanthopoulos

Director/Board Member chez CONNECT BIOPHARMA HOLDINGS LIMITED

Fortune : - $ au 31/03/2024

66 ans
Health Technology
Commercial Services
Finance

Profil

Kleanthis G.
Xanthopoulos
was the founder of Anadys Pharmaceuticals, Inc. (founded in 1992) and SENTÉ, Inc. (California) (founded in 2007), where he holds the position of Director.
He is also the founder of SENTÉ Labs (founded in 2007) and currently serves as Chairman at Stork Capital SARL (since 2020), Director at Irras AB (since 2015), Director at Suzhou Connect Biopharma Co. Ltd.
(since 2020), Director at Connect Biopharma Holdings Ltd.
(since 2020), President at Helios, Inc., Member-Executive Board at BIOCOM, Managing Partner at Vandel Group LLC, and Managing General Partner at Cerus Advisors DMCC (since 2015).
Dr. Xanthopoulos is also the founder of Shoreline Biosciences, Inc...
Dr. Xanthopoulos's former positions include President, Chief Executive Officer & Director at Regulus Therapeutics, Inc. (2007-2015), Chairman at Apricus Biosciences, Inc. (2011-2019), Chairman at Bioniz Therapeutics, Inc. (2015-2016), Director at ZP Opco, Inc., Director at Biotechnology Innovation Organization, Director at J.E.M.
Capital, Inc. (2013-2014), Managing Director at Enterprise Partners Venture Capital (2007), Director at Odyssey Thera, Inc., Director at Aspirus, Inc., Director at Laboratori Derivati Organici SpA (2016-2017), and Independent Director at Zosano Pharma Corp.
(2013-2021).
Dr. Xanthopoulos also served as Senior Vice President at Ionis Pharmaceuticals, Inc. and Vice President-Genomics & Molecular Biology at Aurora Biosciences Corp.
(1997-2000).
He held the position of Associate Professor at Karolinska Institutet and Section Head at the National Human Genome Research Institute (1995-1997).
Dr. Xanthopoulos obtained a doctorate degree from the University of Stockholm in 1986, a graduate degree from the University of Stockholm in 1982, and an undergraduate degree from Aristotle University of Thessaloniki in 1980.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/03/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Kleanthis Xanthopoulos

SociétésPosteDébut
IRRAS AB Director/Board Member 01/06/2015
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 01/12/2020
Stork Capital SARL Chairman 01/06/2020
Director/Board Member 01/11/2020
Chief Executive Officer -
President -
Private Equity Investor 01/01/2015
Vandel Group LLC Corporate Officer/Principal -
Founder 01/01/2007
░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Kleanthis Xanthopoulos

Anciens postes connus de Kleanthis Xanthopoulos

SociétésPosteFin
░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Kleanthis Xanthopoulos

Formation de Kleanthis Xanthopoulos

University of Stockholm Graduate Degree
Aristotle University of Thessaloniki Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kleanthis Xanthopoulos

Relations

100 +

Relations au 1er degré

29

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
IONIS PHARMACEUTICALS, INC.

Health Technology

REGULUS THERAPEUTICS INC.

Health Technology

IRRAS AB

Health Technology

CONNECT BIOPHARMA HOLDINGS LIMITED

Health Technology

Entreprise privées22

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Finance

Health Technology

Commercial Services

Health Services

Health Technology

Government

Retail Trade

Vandel Group LLC

Finance

Health Technology

Stork Capital SARL

Health Technology

SENTÉ Labs

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Kleanthis Xanthopoulos